JEJascha Ell

Jascha Ell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jascha Ell has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Downstaging and Pathological Complete Response of Locally Recurrent Sarcomatoid Renal Cell Carcinoma under Pembrolizumab and Lenvatinib: A Case Report and Review of Literature

    by Jascha Ell, Philipp Balz, Panagiota Manava, Clemens Hüttenbrink

    The advent of immune checkpoint inhibition opened new perspectives for patients with recurrent or metastasized renal cell carcinoma. In case of recurrent disease, surgical resection remains the most promising therapeutic option. Surgical resection is associated with improved overall survival and demonstrated curative potential given complete resection of metastases can be performed. This report presents the case of a patient with local recurrence of dedifferentiated sarcomatoid renal cell carcinoma approximately 1 year after initial open lumbar nephrectomy. After initial evaluation, surgical removal was deemed infeasible and an induction therapy with pembrolizumab and lenvatinib was initiated. After 3 months, corresponding to 5 cycles of pembrolizumab, the tumor showed a partial response on imaging control and was successfully resected en bloc. Histopathological examination of the specimen revealed no evidence of viable neoplastic cells. This is the first report describing a complete pathological response of a locally recurrent dedifferentiated sarcomatoid renal cell carcinoma after treatment with pembrolizumab and lenvatinib. Overall, the combination therapy was well tolerated with a maximum Common Terminology Criteria for Adverse Events Level of Two. These findings underline the potential of multimodal therapeutic strategies for recurrent renal cell carcinoma, such as induction therapies to downstage initially nonresectable masses, and highlight the need for prospective studies to allow for evidence-based treatment plans.


  • Open Access

    Personalized Prediction of Patient Radiation Exposure for Therapy of Urolithiasis: An Application and Comparison of Six Machine Learning Algorithms

    by Clemens Huettenbrink, Wolfgang Hitzl, Florian Distler, Jascha Ell, Josefin Ammon, Sascha Pahernik

    The prediction of radiation exposure is an important tool for the choice of therapy modality and becomes, as a component of patient-informed consent, increasingly important for both surgeon and patient. The final goal is the implementation of a trained and tested machine learning model in a real-time computer system allowing the surgeon and patient to better assess patient’s personal radiation risk. In summary, 995 patients with ureterorenoscopy over a period from May 2016 to December 2019 were included. According to the suggestions based on actual literature evidence, dose area product (DAP) was categorized into ‘low doses’ ≤ 2.8 Gy·cm2 and ‘high doses’ > 2.8 Gy·cm2 for ureterorenoscopy (URS). To forecast the level of radiation exposure during treatment, six different machine learning models were trained, and 10-fold crossvalidated and their model performances evaluated in training and independent test samples. The negative predictive value for low DAP during ureterorenoscopy was 94% (95% CI: 92–96%). Factors influencing the radiation exposure were: age (p = 0.0002), gender (p = 0.011), weight (p < 0.0001), stone size (p < 0.000001), surgeon experience (p = 0.039), number of stones (p = 0.0007), stone density (p = 0.023), use of flexible endoscope (p < 0.0001) and preoperative stone position (p < 0.00001). The machine learning algorithm identified a subgroup of patients of 81% of the total sample, for which highly accurate predictions (94%) were possible allowing the surgeon to assess patient’s personal radiation risk. Patients without prediction (19%), the medical expert can make decisions as usual. Next step will be the implementation of the trained model in real-time computer systems for clinical decision processes in daily practice.


  • Open Access

    Neural Networks Modeling for Prediction of Required Resources for Personalized Endourologic Treatment of Urolithiasis

    by Clemens Huettenbrink, Wolfgang Hitzl, Sascha Pahernik, Jens Kubitz, Valentin Popeneciu, Jascha Ell

    When scheduling surgeries for urolithiasis, the lack of information about the complexity of procedures and required instruments can lead to mismanagement, cancellations of elective surgeries and financial risk for the hospital. The aim of this study was to develop, train, and test prediction models for ureterorenoscopy. Routinely acquired Computer Tomography (CT) imaging data and patient data were used as data sources. Machine learning models were trained and tested to predict the need for laser lithotripsy and to forecast the expected duration of ureterorenoscopy on the bases of 474 patients over a period from May 2016 to December 2019. Negative predictive value for use of laser lithotripsy was 92%, and positive predictive value 91% before application of the reject option, increasing to 97% and 94% after application of the reject option. Similar results were found for duration of surgery at ≤30 min. This combined prediction is possible for 54% of patients. Factors influencing prediction of laser application and duration ≤30 min are age, sex, height, weight, Body Mass Index (BMI), stone size, stone volume, stone density, and presence of a ureteral stent. Neuronal networks for prediction help to identify patients with an operative time ≤30 min who did not require laser lithotripsy. Thus, surgical planning and resource allocation can be optimised to increase efficiency in the Operating Room (OR).